Boundless Bio
the in phase potentiate trial targeting induced replication stress via inhibition | Boundless Bio
Company
Deck Type
IPO
Sector
Industry
Deck date
March 2024
Slide
25 of 51
Related slides by other companies
Ocuphire Pharma
Results
October 2022
zeta phase trial in diabetic | Ocuphire Pharma
Ocuphire Pharma
Results
March 2021
phase trial results conference call | Ocuphire Pharma
Ocuphire Pharma
Results
March 2022
phase trial results conference call | Ocuphire Pharma
Arrival
Results
May 2022
commenced first phase of trials with first bus drivers and technicians public passenger trials expected to commence shortly trials to last months | Arrival
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights